Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lineage plasticity in prostate cancer depends on JAK/STAT inflammatory signaling
Joseph M. Chan, Samir Zaidi, Jillian Love, et al.
Science (2022) Vol. 377, Iss. 6611, pp. 1180-1191
Open Access | Times Cited: 202

Showing 1-25 of 202 citing articles:

Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 348
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 190
Cancer cell plasticity during tumor progression, metastasis and response to therapy
Andrea Pérez-González, Kevin Bévant, Cédric Blanpain
Nature Cancer (2023) Vol. 4, Iss. 8, pp. 1063-1082
Open Access | Times Cited: 137
Numb/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation
Yuman He, Zhongzhong Ji, Yiming Gong, et al.
Cell Reports (2023) Vol. 42, Iss. 2, pp. 112033-112033
Open Access | Times Cited: 66
Apoptotic Mechanisms of Quercetin in Liver Cancer: Recent Trends and Advancements
Gautam Sethi, Prangya Rath, Abhishek Chauhan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 712-712
Open Access | Times Cited: 64
Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies
Yan-Ruide Li, Ying Fang, Zibai Lyu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 61
Therapeutic resistance to anti-oestrogen therapy in breast cancer
Marie Will, Jackson Liang, Ciara Metcalfe, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 673-685
Open Access | Times Cited: 58
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
Masuko Katoh, Yohann Loriot, Giovanni Brandi, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 312-329
Closed Access | Times Cited: 56
The Transcriptional and Epigenetic Landscape of Cancer Cell Lineage Plasticity
Alastair Davies, Amina Zoubeidi, Himisha Beltran, et al.
Cancer Discovery (2023) Vol. 13, Iss. 8, pp. 1771-1788
Closed Access | Times Cited: 49
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Dechao Feng, Weizhen Zhu, Jie Wang, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity
Xiaojie Bian, Wenfeng Wang, Mierxiati Abudurexiti, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 21
Progressive plasticity during colorectal cancer metastasis
Andrew R Moorman, Elizabeth K. Benitez, Francesco Cambuli, et al.
Nature (2024)
Open Access | Times Cited: 15
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Avanish Mishra, Shih‐Bo Huang, Taronish D. Dubash, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
A highly sensitive screening system to evaluate the reversibility of neuroendocrine prostate cancer to prostate adenocarcinoma
Tomohiro Fukui, Kosuke Okasho, Yukiko Okuno, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access | Times Cited: 1
JAK–STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States
Laura E. Stevens, Guillermo Peluffo, Xintao Qiu, et al.
Cancer Research (2022) Vol. 83, Iss. 2, pp. 264-284
Open Access | Times Cited: 57
Trellis tree-based analysis reveals stromal regulation of patient-derived organoid drug responses
María Ramos Zapatero, Alexander Tong, James W. Opzoomer, et al.
Cell (2023) Vol. 186, Iss. 25, pp. 5606-5619.e24
Open Access | Times Cited: 33
Temporal evolution reveals bifurcated lineages in aggressive neuroendocrine small cell prostate cancer trans-differentiation
Chia-Chun Chen, Wendy Tran, Kai Song, et al.
Cancer Cell (2023) Vol. 41, Iss. 12, pp. 2066-2082.e9
Open Access | Times Cited: 32
Cancer Evolution: A Multifaceted Affair
Giovanni Ciriello, Luca Magnani, Sarah J. Aitken, et al.
Cancer Discovery (2023) Vol. 14, Iss. 1, pp. 36-48
Open Access | Times Cited: 26
Cancer cell plasticity and MHC-II–mediated immune tolerance promote breast cancer metastasis to lymph nodes
Pin‐Ji Lei, Ethel R. Pereira, Patrik Andersson, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 9
Open Access | Times Cited: 24
Clinical and translational relevance of intratumor heterogeneity
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 23
Counteracting lineage-specific transcription factor network finely tunes lung adeno-to-squamous transdifferentiation through remodeling tumor immune microenvironment
Shijie Tang, Yun Xue, Zhen Qin, et al.
National Science Review (2023) Vol. 10, Iss. 4
Open Access | Times Cited: 22
The JAK-STAT pathway: from structural biology to cytokine engineering
You Lv, Jianxun Qi, Jeffrey J. Babon, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A. Piha‐Paul, Binghe Xu, Ecaterina E. Dumbrava, et al.
The Oncologist (2024) Vol. 29, Iss. 4, pp. e514-e525
Open Access | Times Cited: 12
FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer
Na Liu, Anran Wang, Mengen Xue, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer
Sheng‐Yu Ku, Yanqing Wang, Maria Mica Garcia, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top